论文部分内容阅读
为进一步评价癌胚抗原(CEA)检测对肺癌病人的临床价值,我们对69例肺癌患者进行了血清CEA含量测定,其中部分病人做了治疗前后的CEA 监测。对象与方法我们共行CEA 检测144例,分为三组;①肺癌组69例,其中男53例,女16例,年龄19～74岁,平均51.75岁。包括肺鳞癌30例,肺腺癌15例,肺未分化癌10例,类癌2例,未能明确分类者12例。②正常组43例,其中男22例,女21例,年龄21～38岁,平均28.22岁,均为本院健康献血员。③肺部良性疾患组
To further evaluate the clinical value of carcinoembryonic antigen (CEA) detection in lung cancer patients, we measured serum CEA levels in 69 patients with lung cancer. Some of these patients had CEA monitoring before and after treatment. Subjects and Methods We conducted a total of 144 CEA tests and were divided into three groups. In the lung cancer group, there were 69 patients, including 53 males and 16 females, aged 19 to 74 years, with an average of 51.75 years. Including 30 cases of lung squamous cell carcinoma, 15 cases of lung adenocarcinoma, 10 cases of lung undifferentiated carcinoma, 2 cases of carcinoid, 12 cases of unclear classification. 243 cases of normal group, including 22 males and 21 females, aged 21 to 38 years old, average 28.22 years old, are healthy blood donors. 3 benign lung disease group